Register   |   Log In Contact Us
Or login with one of the following

Log in



About UroToday International Journal

UroToday International Journal connects global clinicians from the urology community to one of the most extensive online urological disease collections. We focus on fast-tracked information, providing original studies and case reports within months of acceptance so our urologic community can stay up-to-date on emerging evidence that supports clinical practice decisions towards improving patient outcomes.

We provide patient education, CME programs, clinical trial recruitment services, and various articles from around the globe to our over 30,000 subscribers via the computer or mobile device, making our content both current and accessible. On top of our content provided by professional urologists from all over the globe, our editorial board is comprised of leaders in urology across the globe.

For our authors, we provide open access and do not charge for the submission process, editorial review, and publication in UIJ. It is our goal to provide positive support to our authors, as well as an efficient platform to publish their case studies, reviews, and original research.

Editorial Board

  1. Tamir Aboushwareb, Wake Forest University, USA
  2. Neena Agarwala, University of Nebraska Medical Center, USA
  3. Ilker Akyol, GATA Haydarpasa Teaching Hospital, Turkey
  4. Amir Arsanjani, New York Medical College, USA
  5. Ricarda Bauer, Ludwig Maximilian University-Munich, Germany
  6. Wassim Bazzi, University of California-San Diego, USA
  7. Erin Bird, Scott and White Healthcare; Texas A&M University, USA
  8. Tommaso Cai, University of Florence, Italy
  9. John Calleary, North Manchester General Hospital, United Kingdom
  10. Francisco Blasco Casares, Hospital Municipal Badalona, Spain
  11. David Chen, Fox Chase Cancer Center, USA
  12. Steve Chung, Northwestern University, USA
  13. Simone Crivellaro, Universitaria di Udine, Italy
  14. Francisco Cruz, Hospital S Joao and Faculty of Medicine, Portugal
  15. Roger Dmochowski, Vanderbilt University, USA
  16. Marcus Drake, Bristol Urological Institute, United Kingdom
  17. Daniel Eberli, University Hospital - Zurich, Switzerland
  18. Pamela Ellsworth, Warren Alpert School of Medicine, Brown University, USA
  19. Christopher Evans, University of California-Davis, USA
  20. Siavash Falahatkar, Guilan University of Medical Science, Islamic Republic of Iran
  21. Christian Gratzke, Ludwig Maximilian University-Munich, Germany
  22. Amr Hawary, Manchester Royal Infirmary, United Kingdom
  23. Stefan Hinz, Charité Universitätsmedizin Berlin, Germany
  24. Yasuhiko Igawa, University of Tokyo, Japan
  25. Christian Ilie, University of Medicine and Pharmacy, Romania
  26. William Jaffe, Pennsylvania Presbyterian Medical Center, University of Pennsylvania, USA
  27. Mohamed Labib, University Teaching Hospital, Zambia
  28. Thomas Sean Lendvay, Seattle Children's Hospital, University of Washington, USA
  29. Richard Levin, Urodocs PA, USA
  30. Jia-Wen (Kevin) Lu, E-Da Hospital, I-Shou University, Taiwan
  31. Joseph Macaluso, Louisiana State University Medical School, USA
  32. Maxwell Meng, University of California-San Francisco, USA
  33. Walter Merkle, German Diagnostic Clinic, Germany
  34. Grannum Sant, Genzyme Corp, USA
  35. Walter Strohmaier, Klinikum Coburg, Germany
  36. Edward Uchio, VA Connecticut Healthcare System, Yale University School of Medicine, USA
  37. J. Stuart Wolf, University of Michigan, USA

Our Peer Review Process

The editor in chief assigns papers considered for publication to the associate editor who communicates with the author and expert reviewers. A statistician analyzes any statistics included. Other experts may be invited to comment where appropriate. Similar procedures may be used for other contributions to the journal. All manuscripts are subject to copy editing and formatting to conform to UIJ standards.

If a manuscript is sent for revision to an author, whether major or minor, the revised manuscript must be returned within 30 days. If it is not received at the editorial office within this timeframe, it is treated as a new submission and sent out for review to different reviewers.


Volume 1

UIJ Volume 1 2008

Issue 2: August 2008

UIJ Volume 1 Issue 2 August 2008

Issue 1s: June 2008

UIJ Volume 1 Issue 1s June 2008

Issue 5: December 2008

UIJ Volume 1 Issue 5 December 2008

Issue 4: October 2008

UIJ Volume 1 Issue 4 October 2008

Volume 4

UIJ Volume 4 2011

Issue 6: December 2011

UIJ Volume 4 Issue 6 2011

Issue 5: October 2011

UIJ Volume 4 Issue 5 2012

Issue 4: August 2011

UIJ Volume 4 Issue 4 2011

Issue 3: June 2011

UIJ Volume 4 Issue 3 2012

Issue 2: April 2011

UIJ Volume 4 Issue 2 2012

Issue 1: February 2011

UIJ Volume 4 Issue 1 2012

Volume 2

UIJ Volume 2 2009

Issue 6: December 2009

UIJ Volume 2 Issue 6 December 2009

Issue 5: October 2009

UIJ Volume 2 Issue 5 October 2009

Issue 4: August 2009

UIJ Volume 2 Issue 4 August 2009

Issue 3: June 2009

UIJ Volume 2 Issue 3 June 2009

Issue 2: April 2009

UIJ Volume 2 Issue 2 April 2009

Issue 1: February 2009

UIJ Volume 2 Issue 1 February 2009

Volume 3

UIJ Volume 3 2010

Issue 6: December 2010

UIJ Volume 3 Issue 6 2010

Issue 5: October 2010

UIJ Volume 3 Issue 5 2010

Issue 4: August 2010

UIJ Volume 3 Issue 4 2010

Issue 3: June 2010

UIJ Volume 3 Issue 3 2012

Issue 2: April 2010

UIJ Volume 3 Issue 2 2012

Issue 1: February 2010

UIJ Volume 3 Issue 1 2012

UIJ Institutions

UIJ Institutions


CUA 2013

cua xCanadian Urological Association (CUA)
68th Annual Meeting
June 22 - 25, 2013

Niagara Falls, Ontario Canada

SES AUA 2013

aua ses77th Annual Meeting of the
Southeastern Section of the AUA
March 14 - 17, 2013

Williamsburg, VA USA

SUNA 2013

sunaSociety of Urologic Nurses and Associates (SUNA)
2013 Annual Symposium

March 7 - 9, 2013

Savannah, GA USA

SUFU Winter Meeting 2013

sufuSociety for Urodynamics, Female Pelvic Medicine and
Urogenital Reconstruction (SUFU)

2013 Winter Meeting

February 26 - March 2, 2013
Caesars Palace - Las Vegas, NV USA


AUGS 2012

augs American Urogynecologic Society (AUGS)
33rd Annual Scientific Meeting

October 3 - 6, 2012

Chicago Hilton
Chicago, IL USA

SIU 2012

siu 32nd Congress of the Société Internationale d’Urologie

September 30, 2012 - October 4, 2012

Fukuoka International Congress Center (FICC)
Fukuoka, Japan

Coming Soon

WMSM 2012

World Meeting on Sexual Medicine (WMSM)wmsm
2012 Annual Meeting

August 26 - 30, 2012
Sheraton Chicago
Chicago, IL USA

ASCO 2012

asco xxxAmerican Society of Clinical Oncology (ASCO)
2012 Annual Meeting

June 1 - 5, 2012

McCormick Place
Chicago, IL USA

SIR 2012

sirSociety of Interventional Radiology - 37th Annual Scientific Meeting
March 24 - 29, 2012
San Francisco, CA  USA

EAU 2012

eau27th Annual European Association
of Urology (EAU) Congress
February 24 - 28, 2012

Paris, France

GU Cancers Symposium 2012

gucancerssympaltGU Cancers Symposium 2012

February 2 - 4, 2012
San Francisco Marriott Marquis
San Francisco, CA USA
Prostate cancer session highlights sponsored by Bristol-Myers Squibb

CBU 2011

cbuXXXIII Brazilian Congress of Urology
November 22 - 26, 2011
Santa Catarina, Brazil

DGU 2011

Kongress der Deutschendgu Gesellschaft für Urologie (DGU)
German Society of Urology
63rd Annual Congress
September 14 - 17, 2011
Congress Center Hamburg, Germany

ICS 2011

International Continence Society (ICS)ics 41st Annual Meeting
August 29 - September 2, 2011
The Scottish Exhibition and Conference Centre
Glasgow, Scotland UK

EAU 2011


26th Annual European Association of Urology (EAU) Congress

March 18 - 21, 2011

Vienna, Austria

NIDDK UI Symposium

niddk ui sympNIDDK - New Research Directions in
Urinary Incontinence Symposium

January 7 - 9, 2009
Bethesda, MD USA

AACN 2013

aacnAmerican Association of Critical-Care Nurses (AACN)
National Teaching Institute & Critical Care Exposition (NTI)
May 20 - 23, 2013

Boston, Massachusetts USA

ICCS 2013

iccsSimon Foundation for Continence's
Innovating for Continence Conference Series
April 12 - 13, 2013

Chicago, Illinois USA

ASCO 2013

asco xAmerican Society of Clinical Oncology (ASCO)
2013 Annual Meeting

May 31 - June 4, 2013

McCormick Place
Chicago, IL USA

APIC 2013

apic tileAssociation for Professionals in Infection Control
and Epidemiology (APIC)
40th Annual Conference

June 8 - 10, 2013

Ft. Lauderdale, FL USA

ICS 2013

banner ICS-conference-2013

icsInternational Continence Society (ICS)
43rd Annual Scientific Meeting
August 26 - 30, 2013

Barcelona, Spain

ECCO 2013

eccoEuropean Cancer Congress (ECCO)
September 27 - October 1, 2013

Amsterdam, Netherlands

WCE 2013

31st World Congress of Endourology & SWLwce

October 22 - 26, 2013

New Orleans, LA USA

NC AUA 2013

nc aua87th Annual Meeting of the
North Central Section of the AUA
October 8 - 13, 2013

Naples, FL USA

SUO 2013

14th Annual Meeting of the Society of Urologic Oncology (SUO)suo

December 4 - 6, 2013

Bethesda, MD USA

24th Int'l Prostate Cancer Update

24th cap update 24th Int'l. Prostate Cancer Update

February 19 - 22, 2014

Cascade Conference Center
Vail, Colorado USA

SUFU WM 2014

sufu x Society of Urodynamics, Female Pelvic Medicine
and Urogenital Reconstruction (SUFU) Winter Meeting

February 25 - March 1, 2014

Doral Golf Resort and Spa
Miami, Florida USA

SES AUA 2014

aua ses78th Annual Meeting of the
Southeastern Section of the AUA
March 20 - 23, 2014

Hollywood, FL USA


augs iugaAmerican Urogynecologic Society (AUGS) and
the International Urogynecological Association (IUGA)
Joint Scientific Meetings

July 22 - 26, 2014

Washington, DC USA



If you are not redirected to the CAUTI Center in a few seconds CLICK HERE

Clinical Trials

Clinical Trials Optional page text here.

BJUI Mini Reviews

header home80x





bjui 110 9 cover bjui 110 7 cover bjui 110 8 cover

Laparoscopic partial nephrectomy in obese patients: A systematic review and meta-analysis  
This review adds a meta-analysis of these four studies to make the patient cohort larger and to allow for a greater understanding of the procedure in this select group of patients.

Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel
In this article authors report the results of a consensus meeting focused on ultrasonography, the most common used urological imaging method, in relation to focal therapy of prostate cancer.

Urine survivin as a diagnostic biomarker for bladder cancer: A systematic review
In this article, the authors systematically reviewed the available evidenceTo determine the clinical utility of urine survivin as a bladder tumour marker .

Suprapubic catheter insertion using an ultrasound-guided technique and literature review
This paper describes the technique of US-guided needle puncture and SPC insertion to reduce the likelihood of bowel injury.

Urologists and oncologists: Adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)
In this article, recent paradigm shifts in treatment are reviewed with an emphasis on how these treatments may eventually alter the dynamic equilibrium between urology and oncology specialists.

Bilateral testicular germ cell tumours: A systematic review
The aim of this study is to provide a broad overview of BTGCT and to update data focusing on incidence, pathological features, and clinical outcomes of men with BTGCTs.

Surgical simulators in urological training – views of UK training programme directors
This paper provides a discussion on the current use of simulators in surgical training. Its aim is too determine the views of UK urology training programme directors (TPDs) on the availability and use of simulators in urology at present, and to discuss the role that simulators may have in future training.


bju 2010 08 cover bjui 110 5 cover bjui 110 4 cover


The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men
This article examines efficacy and safety data from previously unpublished studies over 2 years of continuous use of Striant SR.

Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full-text journal articles
With relatively low publication rates compared to other international meetings, this review identifies the need for mechanisms to encourage USANZ researchers to convert their abstracts into published articles.

Conservative and radiological management of simple renal cysts: A comprehensive review
The study, for the fi rst time, systematically reviews the indications for follow-up or radiological treatment of simple renal cysts.

Coronary stent management in elective genitourinary surgery
This article reviews the literature and recommends a protocol for clinical management of patients undergoing urological procedures after coronary stent placement.

PCA: Prostate cancer, patient-centred approach or both?
The objective of this article is to highlight the differences and similarities in opinion on prostate cancer management between physicians and patients.

Optimising repeat prostate biopsy decisions and procedures
This review discusses strategies to optimise repeat biopsy procedures in order to better predict the biopsy outcome.

bjui 110 3 cover bjui 110 2 cover bjui 110 1 cover


Probiotics, dendritic cells and bladder cancer
This review considers the addition of probiotics to the diet and whether it may confer benefit by altering rates of bladder tumour recurrence and also alter the response to immune mechanisms involved with the application of intravesical treatments (bacille Calmette-Guérin).

An indwelling urinary catheter for the 21st century
This article provides a critical examination of the design of the indwelling Foley catheter.

Quality-of-care framework in urological cancers: Where do we stand? 

This article aims to delineate quality of care processes, current status of quality indicators for major urological cancers as well as recommend a provisional framework for evaluation of quality for urological procedures.

Urology training: Past, present and future 
This article looks at past and current urological training and suggests emerging and innovative ways to teach the next generation of urologists.  

bjui 109 11 cover bjui 109 9 cover bjui 109 1 cover


Operative experience of urological trainees in the UK
The authors examine trainees’ current operative experience and analyse the changes over recent years. With a notable decrease in experience of certain procedures, they highlight the possible reasons and discuss the implications for future training.

Intraprostatic testosterone and dihydrotestosterone. Part I: Concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer 
Part I of this two-part paper reviews the different methods of steroid hormone measurement and gives an overview of steroid hormone concentrations in normal and diseased prostatic tissue.

Intraprostatic testosterone and dihydrotestosterone. Part II: Concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer 
Part II of this two-piece mini-review examines the effect of medication that alters the male steroid hormone metabolism (i.e. 5-alpha reductase inhibitors, androgen deprivation therapy) on intraprostatic steroid hormone concentrations.

Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present 
This review provides evidence that the minimally invasive prostatectomy literature still fails to meet the standards and critical benchmarks necessary for adequate complications reporting.






December 2011

From Leonardo to da Vinci: The history of robot-assisted surgery in urology
This review highlights the depth of history that underpins the robotic surgical platform we utilise today, whilst also detailing the current place of robot-assisted surgery in urology in 2011.

December 2011

The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: A meta-analysis with comments on gold standard
The purpose of this review was to examine evidence on the sensitivity of fluorescent light cystoscopy (FLC; alternative term photodynamic diagnosis) for urothelial carcinoma in situ (CIS) of the bladder, and to offer a discussion from a histopathology standpoint.


How to develop a simulation programme in urology
This study provides a framework to overcome the challenges of integrating standalone simulation programmes into mainstream urology curricula and discusses the advantages of centralised urology simulation centres and their potential to serve as key adjuncts in the certification and validation process of urologists.



November 2011

Chemotherapy for advanced adrenal cancer: Improvement from a molecular approach?
This review assesses the utility of conventional and novel systematic therapies for adrenal carcinoma, and points the way to future implementation of molecular biology in the design and execution of clinical trails for advanced adrenal carcinoma.


November 2011

Prostatic intraepithelial neoplasia: Its morphological and molecular diagnosis and clinical significance
The aim of this paper was to review the morphological spectrum of prostatic intraepithelial neoplasia (PIN), its relationship to carcinoma of the prostate (PCa) and its clinical significance.



October 2011

What is the current status of revalidation in urology?
This article describes the process of revalidation for urologists, highlights challenges in its practical application and suggests potential improvements to the current strategy of revalidation.


Pelvic floor disorders: Linking genetic risk factors to biochemical changes
We reviewed recent literature on observed biochemical changes in women with SUI and POP, linking them to genetic predisposition.


October 2011

Treating stuttering priapism
In this mini review, the authors have attempted to systematically summarize the published articles on this topic.




September 2011

Critical review of ‘pentafecta’ outcomes after robot-assisted laparoscopic prostatectomy in high-volume centres
This article reviews each of the five arms of ‘pentafecta’ outcomes after robotic prostatectomy performed in high volume centres.


Balancing continence function and oncological outcomes during robot-assisted radical prostatectomy (RARP)
Although the main aim of the robot-assisted laparoscopic prostatectomy (RALP) procedure remain reaching a complete extirpation of the primary tumour, the patients satisfaction can be negatively affected by the presence of UI and/or erectile dysfunction during the follow-up.


September 2011

Training in ureteroscopy: A critical appraisal of the literature
The aim of the present review was to study factors influencing training and the maintenance of skills in performing ureteroscopy (URS).


The economic burden of prostate cancer
Prostate cancer is a major public health concern and is associated with significant healthcare costs.




August 2011

TVT-Secur mini-sling for stress urinary incontinence: A review of outcomes at 12 months
Female stress urinary incontinence (SUI) presents an enormous disease burden to women worldwide, affecting 1 in 3 adult women.



August 2011

Management of the bladder in traumatic injuries of the spinal cord during the First World War and its implications for the current practice of urology
By the turn of the 19th century, the chief cause of death in acute and chronic paraplegia was recognized as renal failure attributable to UTIs caused by inappropriate treatment.

Prognostic implications of lymph node involvement in bladder cancer: Are we understaging using current methods?

Bladder cancer is the second most common genitourinary malignancy, with TCCs comprising ≈90% of primary bladder tumours.


August 2011

Management of urolithiasis in patients after urinary diversions
After urinary diversion patients are at increased risk of long-term complications, including stones of the upper urinary tract and reservoir or conduit.




July 2011

Urological litigation in the UK National Health Service (NHS): An analysis of 14 years of successful claims
The aim of this study was to determine the areas in Urology most prone to successful litigation claims and so provide a guide to where risk management procedures may need to be improved.





June 2011

Predictors of citations in the urological literature
Peer-reviewed journals are used to disseminate important research findings to the scientific community.



June 2011

Adverse events from targeted therapies in advanced renal cell carcinoma: The impact on long-term use
Since the introduction of targeted therapy for the treatment of advanced renal cell carcinoma (RCC) the prognosis of this condition has improved.



May 2011

Outcomes of pharmacological management of nocturia with non-antidiuretic agents: Does statistically significant equal clinically significant?
Nocturia is defined by the 4th International Consultation on Incontinence as the need to wake from sleep one or more times to void.


May 2011

LESSons in minimally invasive urology
Laparoscopic surgery has evolved in an effort to reduce the complications associated with large incisions during ‘open-access’ surgery, leading to improvements in blood loss, recovery time, hospital stay, cosmesis, scar pain and hernia formation.


May 2011

Effect of testosterone administration to men with prostate cancer is unpredictable: A word of caution and suggestions for a registry
The prostate cell population is heterogeneous and comprises, among others, epithelial, basal, neuroendocrine and stem cells, as well as stroma and tissue matrix.

May 2011

Focal therapy in the management of localized prostate cancer
The advent of PSA testing more than two decades ago has improved the early detection of prostate cancer, leading to more men being diagnosed and treated.




April 2011

Evidence-based medicine: Comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate
Luteinizing hormone-releasing hormone analogues are a cornerstone in the management of many clinical situations in prostate cancer patients.


April 2011

A new patient-focused approach to the treatment of metastatic renal cell carcinoma: Establishing customized treatment options
Randomized controlled trials (RCTs) show that six targeted agents – sorafenib, sunitinib, temsirolimus, everolimus, bevacizumab and pazopanib – improve outcome in advanced renal cell carcinoma (RCC).


April 2011

Prostate cancer immunology – an update for urologists
Prostate cancer (CaP) is the most prevalent non-skin malignancy in males in the western world.




March 2011

Risk stratification for benign prostatic hyperplasia (BPH) treatment
In men LUTS are common. BPH, a slowly progressive condition, accounts for most of the symptoms and bother associated with LUTS.



March 2011

The influence of family history on prostate cancer risk: Implications for clinical management
Prostate cancer is the most frequently diagnosed cancer in men in Europe and in the USA.



February 2011

Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings,differential diagnosis and clinical management
A number of well-recognized urothelial lesions with inverted morphology occur in the urinary bladder.


February 2011

The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain
The traditional diagnosis of interstitial cystitis (IC) only recognizes the severe form of the disease. The far more common early and intermittent phases of the disease are not perceived to be part of IC but rather are misdiagnosed as urinary tract infection, urethral syndrome, overactive bladder, chronic prostatitis, urethritis, or a type of gynecologic pelvic pain (such as endometriosis, vulvodynia, or some type of vaginitis).




January 2011

Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt
Schistosomiasis is a parasitic disease caused by flatworms that live in snail-infested fresh water. It is endemic to 74 countries and affects some 200 million people worldwide, causing an estimated 200,000 deaths annually.






December 2010

Is radical prostatectomy a viable therapeutic option in clinically locally advanced (cT3) prostate cancer?
While according to the literature, the current preferred treatment for T3 prostate cancer is a combination of radiotherapy and extended hormone therapy, this review looks at the viability of radical prostatectomy as a therapeutic option.



October 2010

Update on the management of T1 renal cortical tumours
This review examines the range of treatment strategies for the management of patients with small incidental renal cortical tumours - including active surveillance, radiofrequency ablation, cryotherapy, radical nephrectomy and partial nephrectomy.





September 2010

Coffee consumption and risk of prostate cancer: A meta-analysis of epidemiological studies
This review evaluates the association between coffee consumption and the risk of prostate cancer.


Transurethral resection of the prostate stands accused of causing impotence in patients: Should it be found culpable?
This review concentrates on evidence from peer-reviewed published reports and presentations at scientific meetings to determine the level of culpability of transurethral resection of the prostate in male impotence.




August 2010

Management of prostate cancer in older men: Recommendations of a working group of the International Society of Geriatric Urology
The aim of this review is to provide the urologist with a short summary of evidence-based recommendations, including specific decision algorithms, for managing older men with localized or advanced prostate cancer.


Racial variation in the pattern and quality of care for prostate cancer in the USA: Mind the gap
In this review, the authors searched the USA National Library of Medicine PubMed system for articles pertaining to quality indicators in prostate cancer and racial disparities in quality of care for prostate cancer.



July 2010

Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: An update of available treatment options
This review looks at the accepted standard of radical cystectomy for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) upon failure of intravesical bacille Calmette-Guérin (BCG) and critically reviews previous reports on the treatment possibilities available in such a clinical scenario.


New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification
The 2004 WHO classification establishes a change in the treatments for managing non-muscle invasive bladder cancer (NMIBC). The main objective of the guideline is to overcome the controversies surrounding the prognostic value of the intermediate grade of the 1973 WHO classification. The clinical recommendations of the Italian guidelines are based primarily on the new 2004 WHO classification, while definitively abandoning that of 1973.



June 2010

A new era in the treatment of erectile dysfunction: Chronic phosphodiesterase type 5 inhibition
This review provides an examination of clinical studies indicating that chronic PDE5-i regimens for erectile dysfunction are a safe and effective alternative to the classical on-demand dosage.



May 2010

The increasing incidence of mumps orchitis: A comprehensive review
This review examines the epidemiology, clinical presentation, diagnostic methods, treatment options and complications of mumps orchitis, as a complication of mumps virus, with particular emphasis on testicular atrophy, subfertility and infertility.

Methylated genes as potential biomarkers in prostate cancer
This review looks at the promising preliminary results of the use of the methylation status of specific genes as potential tumour biomarkers for the early diagnosis and the risk stratification of patients with prostate cancer.

Current status of metal stents for managing malignant ureteric obstruction 

In this review, the clinical applications of different types of metal stents are discussed, with a specific focus on the latest advances and the future options for managing malignant ureteric obstruction.



April 2010

More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer
This review provides a discussion of how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

The prognostic significance of bladder neck invasion in prostate cancer: Is microscopic involvement truly a T4 disease?
This evidence-based review provides evidence that bladder neck invasion should be assigned within the subset of pT3 stage, and that further improvement of the actual tumour-node-metastasis staging system should be considered.

The management of cyclophosphamide-induced haematuria
This review provides an examination of the key preventative measures and treatment options in the management of cyclophosphamide-induced haematuria.



March 2010

High-grade prostate cancer and finasteride
This review looks at the increase in the prevalence of high-grade prostate tumours in patients who have undergone finasteride therapy.

The prostate cancer gene 3 assay: Indications for use in clinical practice
This review provides a discussion of five clinical cases in which the PCA3 assay can be considered, based on scientific evidence and key patient cases from real-life clinical practice.

Biomarkers in bladder cancer
This article presents an updated review of selected biomarkers within the setting of the Bladder Cancer Prognosis Programme (BCPP) as well as highlighting other recent important developments in bladder cancer research.



February 2010

The effect of age and gender on bladder cancer: A critical review of the literature
This review examines previous reports on the influence of age and gender on the incidence, biology, mortality and treatment of urothelial carcinoma of the bladder (UCB).

Application of mesenchymal stromal cells in urological diseases
This review provides an insight into stem cell hierarchy, defines the properties of MSCs and summarizes recent reports of their administration in urological diseases.



January 2010

The relevance of a hypoxic tumour microenvironment in prostate cancer
This review outlines the role of low-oxygen conditions in prostate cancer and the areas where further studies are required.

Other biomarkers for detecting prostate cancer
This review provides an assessment of current biomarkers, other than PSA, used for prostate cancer detection, and examines their role in the clinical practice.



sh404SEF custom content

Do not delete please!